ERBB2 and cholangiocarcinoma: As demonstrated in the previous literature, HER2 alteration is dominant in the liver-fluke CCA (most of the Asian CCAs) as well as some small fraction of the Western world’s CCAs, and HER2 alterations are also significantly associated with inferior prognosis of CCA patients.